Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
NMR in Biomedicine|September 16, 2017
DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancerStephanie L Barnes, Anna G Sorace, Jennifer G Whisenant, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2010
IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cellsSamuel J Wadsworth, Ryo Atsuta, J Oliver McIntyre, et al.
Translational Oncology|December 16, 2014
Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenograftsJennifer G Whisenant, Anna G Sorace, J Oliver McIntyre, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacyBarbara Fingleton, Ramkumar Menon, Kathy J Carter, et al.
The Biochemical Journal|October 15, 2003
Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activityJ Oliver McIntyre, Barbara Fingleton, K Sam Wells, et al.
Clinical & Experimental Metastasis|September 13, 2008
Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowthMichelle D Martin, Barbara Fingleton, Conor C Lynch, et al.
Magnetic Resonance in Medicine|October 29, 2008
Novel solubility-switchable MRI agent allows the noninvasive detection of matrix metalloproteinase-2 activity in vivo in a mouse modelRéjean Lebel, Beata Jastrzebska, Hélène Therriault, et al.
Journal of Medicinal Chemistry|February 21, 2009
New enzyme-activated solubility-switchable contrast agent for magnetic resonance imaging: from synthesis to in vivo imagingBeata Jastrzebska, Réjean Lebel, Hélène Therriault, et al.
Breast Cancer Research and Treatment|January 22, 2016
Trastuzumab improves tumor perfusion and vascular delivery of cytotoxic therapy in a murine model of HER2+ breast cancer: preliminary resultsAnna G Sorace, C Chad Quarles, Jennifer G Whisenant, et al.
Molecular Imaging and Biology|July 19, 2014
Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenograftsJennifer G Whisenant, J Oliver McIntyre, Todd E Peterson, et al.
Pageof 4